1
|
Arnoni CP, Vendrame TAP, Silva FS, Cortez AJP, Latini FRM, Castilho L. RHCE variant alleles and risk of alloimmunization in Brazilians. Immunohematology 2022; 38:123-129. [PMID: 36789463 DOI: 10.21307/immunohematology-2022-054] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 06/18/2023]
Abstract
Variant RHCE alleles are found mainly in Afro-descendant individuals, as well as in patients with sickle cell disease (SCD). The most common variants are related to the RHCE*ce allele, which can generate partial e and c antigens. Although RHCE variant alleles have been extensively studied, defining their clinical significance is a difficult task. We evaluated the risk of RhCE alloimmunization as a consequence of partial antigens in patients with a positive phenotype transfused with red blood cell (RBC) units with the corresponding antigen. A retrospective study was performed with Brazilian patients, evaluating the number of antigen-positive transfused RBC units (incompatible due to partial antigen) in 27 patients with SCD carrying RHCE variant alleles who did not develop antibodies as well as evaluating the variants present in 12 patients with partial phenotype and correlated antibody (one patient with SCD and 11 patients with other pathologies). Two patients showed variant alleles with molecular changes that had not yet been described. Variant RHCE alleles were identified in a previous study using molecular methods. RHCE*ceVS.01 was the most frequent allele found among the patients without antibodies. Six patients with partial c antigen had a mean of 3.8 c+ RBC units transfused, and 10 patients with partial e antigen were exposed for a mean of 7.2 e+ RBC units. Among the variant alleles found in alloimmunized patients, the most frequent was RHCE*ceAR, which was found in five patients; the antibodies developed were anti-hrS and/or anti-c. Our results showed that RHCE*ceVS.01 is indeed the most frequent variant allele in our cohort of patients with SCD, but the partial antigens that were identified have low risk of alloimmunization. RHCE*ceAR is the most impactful variant in the Brazilian population with high risk of alloimmunization and clinically significant anti-hrS formation.
Collapse
Affiliation(s)
- C P Arnoni
- Technical and Scientific Department, Colsan-Associação Beneficente de Coleta de Sangue, Avenida Jandira 1260, Indianópolis-CEP 04080-006, São Paulo, SP, Brazil
| | - T A P Vendrame
- Technical and Scientific Department, Colsan- Associação Beneficente de Coleta de Sangue, São Paulo, SP, Brazil
| | - F S Silva
- Technical and Scientific Department, Colsan-Associação Beneficente de Coleta de Sangue, São Paulo, SP, Brazil
| | - A J P Cortez
- Medical Department, Colsan-Associação Beneficente de Coleta de Sangue, São Paulo, SP, Brazil
| | - F R M Latini
- Technical and Scientific Department, Colsan-Associação Beneficente de Coleta de Sangue, São Paulo, SP, Brazil
| | - L Castilho
- Hemocentro-Unicamp, Campinas, SP, Brazil
| |
Collapse
|
2
|
Santos TDD, Leal I, Miranda MR, Castilho L. EVALUATION OF THE COST AND EFFECT OF PROPHYLACTIC GENOTYPIC MATCHING ON ALLOIMMUNIZATION AND AUTOIMMUNIZATION IN PATIENTS WITH SICKLE CELL DISEASE (SCD). Hematol Transfus Cell Ther 2022. [DOI: 10.1016/j.htct.2022.09.788] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/06/2022] Open
|
3
|
Araujo CSR, Azeredo SB, Piassa FEC, Machado BA, Hermes CC, Wink GWA, Pasqualotti A, Castilho L. CARACTERIZAÇÃO SOROLÓGICA E MOLECULAR DO ANTÍGENO D FRACO TIPO 18. Hematol Transfus Cell Ther 2022. [DOI: 10.1016/j.htct.2022.09.813] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/05/2022] Open
|
4
|
Araujo CSR, Azeredo SB, Piassa FEC, Machado BA, Hermes CC, Wink GWA, Pasqualotti A, Castilho L. FENÓTIPO RARO DCE/DCE (RYRY) ASSOCIADO A AUSÊNCIA DO ANTÍGENO CELLANO EM UM PACIENTE DO SUL DO BRASIL. Hematol Transfus Cell Ther 2022. [DOI: 10.1016/j.htct.2022.09.817] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022] Open
|
5
|
Santos TDD, Teles B, Castilho L. RISK OF ANTI-D PRODUCTION IN SICKLE CELL DISEASE PATIENTS (SCD) WITH CONVENTIONAL D AND PARTIAL D TRANSFUSED WITH D+ RED BLOOD CELLS. Hematol Transfus Cell Ther 2022. [DOI: 10.1016/j.htct.2022.09.787] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/05/2022] Open
|
6
|
Castilho L, Nance S, Hamilton JR. Investigation of anemia of unknown origin. Immunohematology 2021; 37:1-4. [PMID: 34591382 DOI: 10.21307/immunohematology-2021-022a] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
|
7
|
Vendrame TAP, Silva FSA, Aravechia MG, Santos LD, Costa TH, Sirianni MFM, Pedro TCPM, Cortez AJP, Castilho L, Latini F, Arnoni CP. ANTI-CRA: A FAMILY STUDY OF A BRAZILIAN FAMILY IN MOLECULAR TIMES. Hematol Transfus Cell Ther 2021. [DOI: 10.1016/j.htct.2021.10.532] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022] Open
|
8
|
Rocha W, Castilho L. RH VARIANTS IN BRAZILIAN PATIENTS WITH SICKLE CELL DISEASE (SCD) AND AFRICAN BRAZILIAN DONORS. Hematol Transfus Cell Ther 2021. [DOI: 10.1016/j.htct.2021.10.560] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022] Open
|
9
|
Miranda MR, Leal I, Santos TDD, Gilli S, Castilho L. IMPACT OF PROPHYLACTIC RED BLOOD CELL (RBC) TRANSFUSION WITH EXTENDED ANTIGEN MATCHING ON ALLOIMMUNIZATION IN PATIENTS WITH SICKLE CELL DISEASE (SCD). Hematol Transfus Cell Ther 2021. [DOI: 10.1016/j.htct.2021.10.546] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022] Open
|
10
|
Santos TDD, Miranda MR, Leal I, Gilli S, Castilho L. COMPARISON OF PROPHYLACTIC GENOTYPIC MATCHING WITH PHENOTYPIC MATCHING FOR REDUCING THE RATE OF ALLOIMMUNIZATION AND HEMOLYTIC TRANSFUSION REACTIONS IN PATIENTS WITH SICKLE CELL DISEASE (SCD). Hematol Transfus Cell Ther 2021. [DOI: 10.1016/j.htct.2021.10.535] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022] Open
|
11
|
Miranda M, Leal I, Castilho L, Santos T. CLINICAL OUTCOMES OF SICKLE CELL DISEASE PATIENTS WITH UNEXPECTED RH ANTIBODIES RECEIVING SEROLOGIC RH-MATCHED RED BLOOD CELL UNITS. Hematol Transfus Cell Ther 2020. [DOI: 10.1016/j.htct.2020.10.565] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022] Open
|
12
|
Araújo C, Mattiello J, Brittes L, Meinhart M, Bortolotti P, Fior T, Machado B, Pasqualotti A, Castilho L. ASSOCIATION OF POSITIVE DIRECT ANTIGLOBULIN TEST WITH NONREACTIVE ELUATE AND DRUG-INDUCED IMMUNE HEMOLYTIC ANEMIA. Hematol Transfus Cell Ther 2020. [DOI: 10.1016/j.htct.2020.10.643] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022] Open
|
13
|
Vendrame T, Santos L, Aravechia M, Latini F, Cortez A, Satake M, Castilho L, Arnoni C. ANTICORPO CONTRA ANTÍGENO DE ALTA FREQUÊNCIA, ANTI-JOA EM RECÉM-NASCIDO: RELATO DE CASO. Hematol Transfus Cell Ther 2020. [DOI: 10.1016/j.htct.2020.10.563] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022] Open
|
14
|
Macedo M, Miranda M, Santos T, Leal I, Castilho L. RH ANTIBODIES AS A RESULT OF ALTERED RH EPITOPES ON TRANSFUSED RED CELLS: A CASE SERIES OF 7 BRAZILIAN PATIENTS. Hematol Transfus Cell Ther 2020. [DOI: 10.1016/j.htct.2020.10.581] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022] Open
|
15
|
Santos TD, Macedo MD, Menegati SFP, Gilli S, Castilho L. Challenges in providing compatible blood with Rh genotype‐matching in Brazilian patients with sickle cell disease. Transfus Med 2019; 29:423-429. [DOI: 10.1111/tme.12641] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/10/2019] [Revised: 09/06/2019] [Accepted: 09/22/2019] [Indexed: 11/27/2022]
Affiliation(s)
- T. D. Santos
- Hemocentro Campinas‐UNICAMP Campinas São Paulo Brazil
| | - M. D. Macedo
- Hemocentro Campinas‐UNICAMP Campinas São Paulo Brazil
| | | | - S. Gilli
- Hemocentro Campinas‐UNICAMP Campinas São Paulo Brazil
| | - L. Castilho
- Hemocentro Campinas‐UNICAMP Campinas São Paulo Brazil
| |
Collapse
|
16
|
De Vooght KMK, Lozano M, Bueno JL, Alarcón A, Romera I, Suzuki K, Zhiburt E, Holbro A, Infanti L, Buser A, Hustinx H, Deneys V, Frélik A, Thiry C, Murphy M, Staves J, Selleng K, Greinacher A, Kutner JM, Bonet Bub C, Castilho L, Kaufman RM, Colling ME, Perseghin P, Incontri A, Dassi M, Brilhante D, Macédo A, Cserti-Gazdewich C, Pendergrast JM, Hawes J, Lundgren MN, Storry JR, Jain A, Marwaha N, Sharma RR. International Forum on typing and matching strategies in patients on anti-CD38 monoclonal therapy. Vox Sang 2018; 113. [PMID: 29947125 DOI: 10.1111/vox.12652] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
Affiliation(s)
| | | | - J-L Bueno
- Haematology and Haemotherapy Department, Hospital Universitario Puerta de Hierro - Majadahonda, Joaquín Rodrigo 2, Majadahonda, 28222, Madrid, Spain
| | - A Alarcón
- Haematology and Haemotherapy Department, Hospital Universitario Puerta de Hierro - Majadahonda, Joaquín Rodrigo 2, Majadahonda, 28222, Madrid, Spain
| | - I Romera
- Haematology and Haemotherapy Department, Hospital Universitario Puerta de Hierro - Majadahonda, Joaquín Rodrigo 2, Majadahonda, 28222, Madrid, Spain
| | - K Suzuki
- Department of Internal Medicine, Japanese Red Cross Medical Center, 4-1-22 Hiroo, Shibuya-ku, Tokyo, 150-8935, Japan
| | - E Zhiburt
- Blood Transfusion Department, Pirogov Russian National Medical Surgical Center, 70, Nizhnyaya Pervomaiskaya ul, Moscow, 105203, Russia
| | - A Holbro
- Regional Blood Transfusion Service, Swiss Red Cross, Basel, Switzerland
- Hematology, University Hospital Basel, Hebelstrasse 10, Basel, 4031, Switzerland
| | - L Infanti
- Regional Blood Transfusion Service, Swiss Red Cross, Basel, Switzerland
- Hematology, University Hospital Basel, Hebelstrasse 10, Basel, 4031, Switzerland
| | - A Buser
- Regional Blood Transfusion Service, Swiss Red Cross, Basel, Switzerland
- Hematology, University Hospital Basel, Hebelstrasse 10, Basel, 4031, Switzerland
| | - H Hustinx
- National Reference Laboratory, Swiss Blood Transfusion Service, Interregional Blood Transfusion Service SRC Ltd, Murtenstrasse 133, Bern, 3008, Switzerland
| | - V Deneys
- Immunohematology Laboratory, CHU UCL Namur, Godinne Hospital, Rue Dr Gaston Therasse 1, 5530, Yvoir, Belgium
| | - A Frélik
- Immunohematology Laboratory, CHU UCL Namur, Godinne Hospital, Rue Dr Gaston Therasse 1, 5530, Yvoir, Belgium
| | - C Thiry
- Immunohematology Laboratory, CHU UCL Namur, Godinne Hospital, Rue Dr Gaston Therasse 1, 5530, Yvoir, Belgium
| | - M Murphy
- NHS Blood & Transplant, Oxford University Hospitals, NHS Foundation Trust, John Radcliffe Hospital, Headley Way, Headington, Oxford, OX3 9DU, UK
| | - J Staves
- Oxford University Hospitals, NHS Foundation Trust, John Radcliffe Hospital, Headley Way, Headington, Oxford, OX3 9DU, UK
| | - K Selleng
- Institut für Immunologie und Transfusionsmedizin, Universitätsmedizin Greifswald, Sauerbruchstr, Greifswald, 17475, Germany
| | - A Greinacher
- Institut für Immunologie und Transfusionsmedizin, Universitätsmedizin Greifswald, Sauerbruchstr, Greifswald, 17475, Germany
| | - J M Kutner
- Departamento de Hemoterapia, Hospital Israelita Albert Einstein, Av. Albert Einstein, 627/701 - Morumbi, São Paulo - SP, 05652-900, Brazil
| | - C Bonet Bub
- Departamento de Hemoterapia, Hospital Israelita Albert Einstein, Av. Albert Einstein, 627/701 - Morumbi, São Paulo - SP, 05652-900, Brazil
| | - L Castilho
- Departamento de Hemoterapia, Hospital Israelita Albert Einstein, Av. Albert Einstein, 627/701 - Morumbi, São Paulo - SP, 05652-900, Brazil
| | - R M Kaufman
- Brigham and Women's Hospital, Blood Bank, Amory 260, 75 Francis Street, Boston, MA, 02115, USA
| | - M E Colling
- Brigham and Women's Hospital, Blood Bank, Amory 260, 75 Francis Street, Boston, MA, 02115, USA
| | - P Perseghin
- Laboratorio di Criobiologia, UOS Aferesi e nuove tecnologie trasfusionali, ASST-Monza Ospedale San Gerardo, Via Pergolesi 33, 20900, Monza, Italy
| | - A Incontri
- Laboratorio di Immunoematologia, UOS Aferesi e nuove tecnologie trasfusionale, ASST-Monza, Ospedale San Gerardo, Via Pergolesi 33, 20900, Monza, Italy
| | - M Dassi
- Laboratorio di Immunoematologia, UOS Aferesi e nuove tecnologie trasfusionale, ASST-Monza, Ospedale San Gerardo, Via Pergolesi 33, 20900, Monza, Italy
| | - D Brilhante
- Serviço de Imunohemoterapia, Instituto Português de Oncologia Lisboa Francisco Gentil, EPE, Lisboa, Portugal
| | - A Macédo
- Serviço de Imunohemoterapia, Instituto Português de Oncologia Lisboa Francisco Gentil, EPE, Lisboa, Portugal
| | - C Cserti-Gazdewich
- Department of Laboratory Hematology (Transfusion Medicine), University Health Network, 200 Elizabeth Street, UHN TGH BTL 3EC-306, Toronto, ON, M5G 2C4, Canada
| | - J M Pendergrast
- Department of Laboratory Hematology (Transfusion Medicine), University Health Network, 200 Elizabeth Street, UHN TGH BTL 3EC-306, Toronto, ON, M5G 2C4, Canada
| | - J Hawes
- Department of Laboratory Hematology (Transfusion Medicine), University Health Network, 200 Elizabeth Street, UHN TGH BTL 3EC-306, Toronto, ON, M5G 2C4, Canada
| | - M N Lundgren
- Deparment of Clinical Immunology and Transfusion Medicine, Labmedicin Skane, Akutgatan 8, Lund, SE-22185, Sweden
| | - J R Storry
- Deparment of Clinical Immunology and Transfusion Medicine, Labmedicin Skane, Akutgatan 8, Lund, SE-22185, Sweden
| | - A Jain
- Department of Transfusion Medicine, Postgraduate Institute of Medical Education and Research, Sector 12, Chandigarh, 160012, India
| | - N Marwaha
- Department of Transfusion Medicine, Postgraduate Institute of Medical Education and Research, Sector 12, Chandigarh, 160012, India
| | - R R Sharma
- Department of Transfusion Medicine, Postgraduate Institute of Medical Education and Research, Sector 12, Chandigarh, 160012, India
| |
Collapse
|
17
|
de Vooght KMK, Lozano M, Bueno JL, Alarcón A, Romera I, Suzuki K, Zhiburt E, Holbro A, Infanti L, Buser A, Hustinx H, Deneys V, Frélik A, Thiry C, Murphy M, Staves J, Selleng K, Greinacher A, Kutner JM, Bonet Bub C, Castilho L, Kaufman R, Colling ME, Perseghin P, Incontri A, Dassi M, Brilhante D, Macêdo A, Cserti-Gazdewich C, Pendergrast JM, Hawes J, Lundgren MN, Storry JR, Jain A, Marwaha N, Sharma RR. Vox Sanguinis International Forum on typing and matching strategies in patients on anti-CD38 monoclonal therapy: summary. Vox Sang 2018; 113:492-498. [PMID: 29781081 DOI: 10.1111/vox.12653] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/01/2023]
Affiliation(s)
- K M K de Vooght
- Department of Clinical Chemistry and Haematology, University Medical Center Utrecht, Utrecht, The Netherlands
| | - M Lozano
- Department of Hemotherapy and Hemostasis, University Clinic Hospital, University of Barcelona, Barcelona, Spain
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
18
|
Daniels G, Finning K, Lozano M, Hyland CA, Liew YW, Powley T, Castilho L, Bonet Bub C, Kutner JM, Banch Clausen F, Christiansen M, Sulin K, Haimila K, Legler TJ, Lambert M, Ryan H, Ní Loingsigh S, Matteocci A, Pierelli L, Dovc Drnovsek T, Bricl I, Nogués N, Muñiz-Diaz E, Olsson ML, Wikman A, de Haas M, van der Schoot CE, Massey E, Westhoff CM. Vox Sanguinis International Forum on application of fetal blood grouping: summary. Vox Sang 2017; 113:198-201. [DOI: 10.1111/vox.12616] [Citation(s) in RCA: 10] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/31/2023]
Affiliation(s)
| | - K. Finning
- International Blood Group Reference Lab; NHS Blood and Transplant; Northway, Filton Bristol BS34 7QH UK
| | - M. Lozano
- Department of Hemotherapy and Hemostasis; University Clinic Hospital; University of Barcelona; Barcelona Spain
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
19
|
Daniels G, Finning K, Lozano M, Hyland CA, Liew YW, Powley T, Castilho L, Bonet Bub C, Kutner JM, Banch Clausen F, Christiansen M, Sulin K, Haimila K, Legler TJ, Lambert M, Ryan H, Ní Loingsigh S, Matteocci A, Pierelli L, Dovc Drnovsek T, Bricl I, Nogués N, Muñiz-Diaz E, Olsson ML, Wikman A, de Haas M, van der Schoot CE, Massey E, Westhoff CM. Vox Sanguinis International Forum on application of fetal blood grouping. Vox Sang 2017; 113:e26-e35. [DOI: 10.1111/vox.12615] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
Affiliation(s)
| | | | | | - C. A. Hyland
- Australian Red Cross Blood Service, Research and Development; 44 Musk Avenue, Kelvin Grove Brisbane Qld 4059 Australia
| | - Y.-W. Liew
- Australian Red Cross Blood Service, Research and Development; 44 Musk Avenue, Kelvin Grove Brisbane Qld 4059 Australia
| | - T. Powley
- Australian Red Cross Blood Service, Research and Development; 44 Musk Avenue, Kelvin Grove Brisbane Qld 4059 Australia
| | - L. Castilho
- Departamento de Hemoterapia; Hospital Israelita Albert Einstein; Avenida Albert Einstein, 627-3° andar Bloco E CEP: 05651-901 São Paulo SP Brazil
| | - C. Bonet Bub
- Departamento de Hemoterapia; Hospital Israelita Albert Einstein; Avenida Albert Einstein, 627-3° andar Bloco E CEP: 05651-901 São Paulo SP Brazil
| | - J. M. Kutner
- Departamento de Hemoterapia; Hospital Israelita Albert Einstein; Avenida Albert Einstein, 627-3° andar Bloco E CEP: 05651-901 São Paulo SP Brazil
| | - F. Banch Clausen
- Laboratory of Blood Genetics, Rigshospitalet, Section 2034, Department of Clinical Immunology; Copenhagen University Hospital; Blegdamsvej 9 Copenhagen Denmark
| | - M. Christiansen
- Department of Clinical Immunology; Aarhus University Hospital; Palle Juul-Jensens Boulevard 99 8200 Aarhus N Denmark
| | - K. Sulin
- Blood Group Unit; Finnish Red Cross Blood Service; Kivihaantie 7 FI-00310 Helsinki Finland
| | - K. Haimila
- Blood Group Unit; Finnish Red Cross Blood Service; Kivihaantie 7 FI-00310 Helsinki Finland
| | - T. J. Legler
- Department of Transfusion Medicine; University Medical Center Göttingen; Georg-August-Universität; Robert-Koch-Str. 40 Göttingen 37075 Germany
| | - M. Lambert
- Irish Blood Transfusion Service; Blood Group Genetics; National Blood Centre; James's Street Dublin 8 Ireland
| | - H. Ryan
- Irish Blood Transfusion Service; Blood Group Genetics; National Blood Centre; James's Street Dublin 8 Ireland
| | - S. Ní Loingsigh
- Irish Blood Transfusion Service; Blood Group Genetics; National Blood Centre; James's Street Dublin 8 Ireland
| | - A. Matteocci
- Department of Transfusion Medicine; San Camillo Forlanini Hospital; Circonvallazione Gianicolense 87 00152 Roma Italy
| | - L. Pierelli
- Department of Experimental Medicine; Sapienza University of Rome; Piazzale Aldo Moro 5 00185 Roma Italy
- Department of Transfusion Medicine; San Camillo Forlanini Hospital; Circonvallazione Gianicolense 87 00152 Roma Italy
| | - T. Dovc Drnovsek
- Department of Immunohematology; Blood Transfusion Centre of Slovenia; Slajmerjeva 6 SI-Ljubljana Slovenia
| | - I. Bricl
- Department of Immunohematology; Blood Transfusion Centre of Slovenia; Slajmerjeva 6 SI-Ljubljana Slovenia
| | - N. Nogués
- Immunohematology Department; Banc de Sang i Teixits; Passeig de Taulat 116 08005 Barcelona Spain
| | - E. Muñiz-Diaz
- Immunohematology Department; Banc de Sang i Teixits; Passeig de Taulat 116 08005 Barcelona Spain
| | - M. L. Olsson
- Department of Laboratory Medicine; Lund University; Lund Sweden
- Department of Clinical Immunology and Transfusion Medicine; LabMedicine; Office of Medical Services; Region Skåne Lund Sweden
| | - A. Wikman
- Department of Clinical Immunology and Transfusion Medicine; Karolinska University Hospital and Karolinska Institutet; Stockholm Sweden
| | - M. de Haas
- Sanquin Diagnostic Services; Department of Immunohematology Diagnostics; Sanquin Research; Plesmanlaan 125 1066 CX Amsterdam The Netherlands
- Center for Clinical Transfusion Research; Leiden The Netherlands
- Department of Immunohematology and Blood Transfusion; Leiden University Medical Center; Leiden The Netherlands
| | - C. E. van der Schoot
- Sanquin Research; Plesmanlaan 125 1066 CX Amsterdam The Netherlands
- Department of Experimental Immunohematology; Sanquin Research; Amsterdam The Netherlands
- Landsteiner Laboratory; Academic Medical Centre; University of Amsterdam; Amsterdam The Netherlands
| | - E. Massey
- Diagnostic and Therapeutic Services; NHS Blood and Transplant; North Bristol Park, Northway Filton Bristol BS34 7QH UK
| | - C. M. Westhoff
- Immunohematology and Genomics; New York Blood Center; 310 E 67th St New York NY 10065 USA
| |
Collapse
|
20
|
Rodrigues C, Sell AM, Guelsin GAS, Higa TT, Pagliarini e Silva S, Macedo LC, Sippert EÂ, de Alencar JB, Zanette Â, Acorsi CRL, Castilho L, Visentainer JEL. HLA polymorphisms and risk of red blood cell alloimmunisation in polytransfused patients with sickle cell anaemia. Transfus Med 2017; 27:437-443. [DOI: 10.1111/tme.12459] [Citation(s) in RCA: 10] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/16/2016] [Revised: 07/05/2017] [Accepted: 08/09/2017] [Indexed: 02/06/2023]
Affiliation(s)
- C. Rodrigues
- Immunogenetics Laboratory, Basic Health Sciences Department; State University of Maringa; Maringa PR Brazil
| | - A. M. Sell
- Immunogenetics Laboratory, Basic Health Sciences Department; State University of Maringa; Maringa PR Brazil
| | - G. A. S. Guelsin
- Research Laboratory of Molecular Blood Group, Hematology and HemotherapyCenter; State University of Campinas; Campinas SP Brazil
| | - T. T. Higa
- Maringa Regional Blood Center; Maringa PR Brazil
| | | | - L. C. Macedo
- Immunogenetics Laboratory, Basic Health Sciences Department; State University of Maringa; Maringa PR Brazil
| | - E. Â. Sippert
- Research Laboratory of Molecular Blood Group, Hematology and HemotherapyCenter; State University of Campinas; Campinas SP Brazil
| | - J. B. de Alencar
- Immunogenetics Laboratory, Basic Health Sciences Department; State University of Maringa; Maringa PR Brazil
| | - Â. Zanette
- Bahia Hematology and HemotherapyCenter; Salvador BA Brazil
| | - C. R. L. Acorsi
- Department of Statistics; State University of Maringa; Maringa PR Brazil
| | - L. Castilho
- Research Laboratory of Molecular Blood Group, Hematology and HemotherapyCenter; State University of Campinas; Campinas SP Brazil
| | - J. E. L. Visentainer
- Immunogenetics Laboratory, Basic Health Sciences Department; State University of Maringa; Maringa PR Brazil
| |
Collapse
|
21
|
Storry JR, Castilho L, Chen Q, Daniels G, Denomme G, Flegel WA, Gassner C, de Haas M, Hyland C, Keller M, Lomas-Francis C, Moulds JM, Nogues N, Olsson ML, Peyrard T, van der Schoot CE, Tani Y, Thornton N, Wagner F, Wendel S, Westhoff C, Yahalom V. International society of blood transfusion working party on red cell immunogenetics and terminology: report of the Seoul and London meetings. ACTA ACUST UNITED AC 2016; 11:118-122. [PMID: 29093749 DOI: 10.1111/voxs.12280] [Citation(s) in RCA: 49] [Impact Index Per Article: 6.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
Abstract
The Working Party has met twice since the last report: in Seoul, South Korea 2014, and in London, UK 2015, both in association with the International Society of Blood Transfusion (ISBT) Congress. As in previous meetings, matters pertaining to blood group antigen nomenclature were discussed. Eleven new blood group antigens were added to seven blood group systems. This brings the current total of blood group antigens recognized by the ISBT to 346, of which 308 are clustered within 36 blood groups systems. The remaining 38 antigens are currently unassigned to a known blood group system.
Collapse
Affiliation(s)
- J R Storry
- Department of Clinical Immunology and Transfusion Medicine, Office for Medical Services, Lund, Sweden
| | - L Castilho
- University of Campinas/Hemocentro, Campinas, Brazil
| | - Q Chen
- Jiangsu Province Blood Center, Nanjing, China
| | - G Daniels
- Bristol Institute for Transfusion Sciences, NHS Blood and Transplant, Bristol, UK
| | - G Denomme
- Blood Center of Wisconsin, Milwaukee, WI, USA
| | - W A Flegel
- Department of Transfusion Medicine, Clinical Center, National Institutes of Health, Bethesda, USA
| | - C Gassner
- Blutspende Zurich, Zurich, Switzerland
| | - M de Haas
- Sanquin Blood Supply Foundation, Amsterdam, The Netherlands
| | - C Hyland
- Australian Red Cross Blood Services, Brisbane, Qld, Australia
| | - M Keller
- American Red Cross Blood Services, Philadelphia, PA, USA
| | | | | | - N Nogues
- Banc de Sang i Teixits, Barcelona, Spain
| | - M L Olsson
- Department of Laboratory Medicine, Division of Hematology and Transfusion Medicine, Lund University, Lund, Sweden
| | - T Peyrard
- Institut National de la Transfusion Sanguine, Département Centre National de Référence pour les Groupes Sanguins, Inserm UMR_S1134, Paris, France
| | | | - Y Tani
- Osaka Red Cross Blood Center, Osaka, Japan
| | - N Thornton
- International Blood Group Reference Laboratory, NHS Blood and Transplant, Bristol, UK
| | - F Wagner
- Red Cross Blood Service NSTOB, Springe, Germany
| | - S Wendel
- Blood Bank, Hospital Sirio-Libanes, São Paulo, Brazil
| | - C Westhoff
- New York Blood Center, New York, NY, USA
| | - V Yahalom
- NBGRL Magen David Adom, Ramat Gan, Israel
| |
Collapse
|
22
|
Prisco Arnoni C, Guilhem Muniz J, de Paula Vendrame TA, de Medeiros Person R, Roche Moreira Latini F, Castilho L. RHCEvariants inherited with alteredRHDalleles in Brazilian blood donors. Transfus Med 2016; 26:285-90. [DOI: 10.1111/tme.12309] [Citation(s) in RCA: 15] [Impact Index Per Article: 1.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/08/2015] [Revised: 03/31/2016] [Accepted: 04/01/2016] [Indexed: 11/28/2022]
Affiliation(s)
- C. Prisco Arnoni
- Technical scientific department Colsan - Associação Beneficente de Coleta de Sangue; São Paulo SP Brazil
| | - J. Guilhem Muniz
- Technical scientific department Colsan - Associação Beneficente de Coleta de Sangue; São Paulo SP Brazil
| | - T. A. de Paula Vendrame
- Technical scientific department Colsan - Associação Beneficente de Coleta de Sangue; São Paulo SP Brazil
| | - R. de Medeiros Person
- Technical scientific department Colsan - Associação Beneficente de Coleta de Sangue; São Paulo SP Brazil
| | - F. Roche Moreira Latini
- Technical scientific department Colsan - Associação Beneficente de Coleta de Sangue; São Paulo SP Brazil
| | - L. Castilho
- Molecular Immunohematology Laboratory Hemocentro - Unicamp; Campinas SP Brazil
| |
Collapse
|
23
|
Sanaiotti TM, Junqueira TG, Palhares V, Aguiar-Silva FH, Henriques LMP, Oliveira G, Guimarães VY, Castro V, Mota D, Trombin DF, Villar DNA, Lara KM, Fernandes D, Castilho L, Yosheno E, Alencar RM, Cesca L, Dantas SM, Laranjeiras TO, Mathias PC, Mendonça CV. Abundance of Harpy and Crested Eagles from a reservoir-impact area in the Low- and Mid-Xingu River. BRAZ J BIOL 2015; 75:190-204. [PMID: 26691093 DOI: 10.1590/1519-6984.00614bm] [Citation(s) in RCA: 10] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/03/2014] [Accepted: 06/09/2015] [Indexed: 11/22/2022] Open
Abstract
In the Brazilian Amazon, two monospecific genera, the Harpy Eagle and Crested Eagle have low densities and are classified by IUCN as Near Threatened due to habitat loss, deforestation, habitat degradation and hunting. In this study, we evaluate occurrence of these large raptors using the environmental surveys database from Belo Monte Hydroelectric Power Plant. Integrating the dataset from two methods, we plotted a distribution map along the Xingu River, including records over a 276-km stretch of river. Terrestrial surveys (RAPELD method) were more efficient for detecting large raptors than standardized aquatic surveys, although the latter were complementary in areas without modules. About 53% of the records were obtained during activities of wildlife rescue/flushing, vegetation suppression or in transit. Between 2012 and 2014, four Harpy Eagles were removed from the wild; two shooting victims, one injured by collision with power lines and one hit by a vehicle. Also, seven nests were mapped. The mean distance between Harpy Eagle records was 15 km along the river channel, with a mean of 20 km between nests near the channel, which allowed us to estimate 20 possible pairs using the alluvial forest, riverine forest and forest fragments. Territories of another ten pairs will probably be affected by inundation of the Volta Grande channel, which is far from the main river. The average distance between Crested Eagle records was 16 km along the river channel. The only nest found was 1.3 km away from a Harpy Eagle nest. The remnant forests are under threat of being replaced by cattle pastures, so we recommend that permanently protected riparian vegetation borders (APP) be guaranteed, and that forest fragments within 5 km of the river be conserved to maintain eagle populations.
Collapse
Affiliation(s)
- T M Sanaiotti
- Coordenação de Pesquisas em Biodiversidade, Instituto Nacional de Pesquisas da Amazônia, Manaus, AM, Brazil
| | - T G Junqueira
- BIOTA Projetos e Consultoria Ambiental Ltda, Goiânia, GO, Brazil
| | - V Palhares
- Leme Engenharia Ltda, Belo Horizonte, MG, Brazil
| | - F H Aguiar-Silva
- Programa de Pós-graduação em Ecologia, Instituto Nacional de Pesquisas da Amazônia, Manaus, AM, Brazil
| | - L M P Henriques
- Coordenação de Pesquisas em Biodiversidade, Instituto Nacional de Pesquisas da Amazônia, Manaus, AM, Brazil
| | - G Oliveira
- Leme Engenharia Ltda, Belo Horizonte, MG, Brazil
| | - V Y Guimarães
- BIOTA Projetos e Consultoria Ambiental Ltda, Goiânia, GO, Brazil
| | - V Castro
- BIOTA Projetos e Consultoria Ambiental Ltda, Goiânia, GO, Brazil
| | - D Mota
- BIOTA Projetos e Consultoria Ambiental Ltda, Goiânia, GO, Brazil
| | - D F Trombin
- BIOTA Projetos e Consultoria Ambiental Ltda, Goiânia, GO, Brazil
| | - D N A Villar
- Systema Naturae Consultoria Ambiental Ltda, Goânia, GO, Brazil
| | - K M Lara
- BIOTA Projetos e Consultoria Ambiental Ltda, Goiânia, GO, Brazil
| | - D Fernandes
- BIOTA Projetos e Consultoria Ambiental Ltda, Goiânia, GO, Brazil
| | - L Castilho
- BIOTA Projetos e Consultoria Ambiental Ltda, Goiânia, GO, Brazil
| | - E Yosheno
- BIOTA Projetos e Consultoria Ambiental Ltda, Goiânia, GO, Brazil
| | - R M Alencar
- BIOTA Projetos e Consultoria Ambiental Ltda, Goiânia, GO, Brazil
| | - L Cesca
- BIOTA Projetos e Consultoria Ambiental Ltda, Goiânia, GO, Brazil
| | - S M Dantas
- Museu Paraense Emilio Goeldi, Belém, PA, Brazil
| | - T O Laranjeiras
- Instituto Chico Mendes de Conservação da Biodiversidade, Boa Vista, RR, Brazil
| | | | | |
Collapse
|
24
|
Yazer MH, Lozano M, Crighton G, Greenway A, Comande M, Savoia H, Wood E, Gilli S, Castilho L, Saad STO, Galactéros F, Noizat-Pirenne F, Pazgal I, Stark P, Orlin Y, Perseghin P, Masera N, Cela E, Anguita J, Wikman A, Delaney M. Transfusion service management of sickle-cell disease patients. Vox Sang 2015; 110:288-94. [PMID: 26177989 DOI: 10.1111/vox.12296] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
25
|
Storry JR, Castilho L, Daniels G, Flegel WA, Garratty G, de Haas M, Hyland C, Lomas-Francis C, Moulds JM, Nogues N, Olsson ML, Poole J, Reid ME, Rouger P, van der Schoot E, Scott M, Tani Y, Yu LC, Wendel S, Westhoff C, Yahalom V, Zelinski T. International Society of Blood Transfusion Working Party on red cell immunogenetics and blood group terminology: Cancun report (2012). Vox Sang 2014; 107:90-6. [PMID: 24372289 PMCID: PMC5661873 DOI: 10.1111/vox.12127] [Citation(s) in RCA: 46] [Impact Index Per Article: 4.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/11/2013] [Accepted: 11/14/2013] [Indexed: 12/22/2022]
Abstract
The International Society of Blood Transfusion Working Party on red cell immunogenetics and blood group terminology convened during the International congress in Cancun, July 2012. This report details the newly identified antigens in existing blood group systems and presents three new blood group systems.
Collapse
Affiliation(s)
- J R Storry
- Clinical Immunology and Transfusion Medicine, University and Regional Laboratories, Lund, Sweden
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
26
|
Mota M, Dezan M, Valgueiro MC, Sakashita AM, Kutner JM, Castilho L. RHD allelic identification among D-Brazilian blood donors as a routine test using pools of DNA. J Clin Lab Anal 2012; 26:104-8. [PMID: 22467325 DOI: 10.1002/jcla.21489] [Citation(s) in RCA: 18] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/06/2022] Open
Abstract
BACKGROUND RHD alleles leading to a reduced expression of D antigen of the red blood cell (RBC) surface may be erroneously typed as D- by serology and may cause anti-D immunizations when transfused to recipients. METHODS To determine the occurrence of such alleles among apparent D- blood donors, molecular typing was implemented as a routine test using a pool of DNA. A total of 2,450 pretyped D- samples were tested in pools of 10 for the RHD-specific polymorphism in intron 4 and exon 7. Samples in polymer chain reaction (PCR) positive pools were individually reevaluated by exon-specific PCRs, sequencing, and serologic methods. RESULTS Among 2,450 serologically D- blood donor samples tested, 101 (4.1%) carried the RHD gene. Nonfunctional RHD (RHDψ, RHD*CE(2-9)-D, and RHD*CE(3-7)-D), different weak D alleles such as RHD*weak D type 1, RHD*weak D type 4.3, RHD*weak D type 5, RHD*weak D type 38, and RHD*DEL were identified. CONCLUSION We employed a PCR-based assay for RHD as a routine test using pools of ten DNA blood donor samples. The integration of RHD genotyping into the routine screening program using pools of DNA samples was straightforward. As a consequence, 19 (0.8%) blood donors carrying a weak D and Del phenotypes with the potential of causing anti-D immunizations in recipients were reclassified as D+. For each population, it would be necessary to adapt the RHD genotyping strategy to the spectrum of prevalent alleles.
Collapse
Affiliation(s)
- Mariza Mota
- Department of Hemotherapy, Albert Einstein Hospital, São Paulo, SP, Brazil.
| | | | | | | | | | | |
Collapse
|
27
|
Castilho L, Monti C, Ferreira U, Reís L, Símóes F, Meirelles A, Kawakami N, Ulhman E. PO-212 IODINE-125 BRACHYTHERAPY: PSA NADIR LESS THAN 1NG/ML AS PROGNOSTIC FACTOR. Radiother Oncol 2012. [DOI: 10.1016/s0167-8140(12)72178-3] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
|
28
|
Storry JR, Castilho L, Daniels G, Flegel WA, Garratty G, Francis CL, Moulds JM, Moulds JJ, Olsson ML, Poole J, Reid ME, Rouger P, van der Schoot E, Scott M, Smart E, Tani Y, Yu LC, Wendel S, Westhoff C, Yahalom V, Zelinski T. International Society of Blood Transfusion Working Party on red cell immunogenetics and blood group terminology: Berlin report. Vox Sang 2011; 101:77-82. [PMID: 21401621 DOI: 10.1111/j.1423-0410.2010.01462.x] [Citation(s) in RCA: 71] [Impact Index Per Article: 5.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
Affiliation(s)
- J R Storry
- Clinical Immunology and Transfusion Medicine, University and Regional Laboratories, Lund, Sweden.
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
29
|
Halter Hipsky C, da Costa DC, Omoto R, Zanette A, Castilho L, Reid ME. Prevalence of RHD*DOL and RHCE*ce(818T) in two populations. Immunohematology 2011; 27:66-67. [PMID: 22356522] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 05/31/2023]
Abstract
The alleles RHCE*ceBI (RHCE*ce 48C, 712G, 818T, 1132G) and RHCE*ceSM (RHCE*ce 48C, 712G, 818T) encode the low-prevalence Rh antigen STEM. These alleles frequently travel in cis with RHD*DOL. To estimate the frequency of these alleles, we tested a total of more than 700 samples in two populations. Blood samples were obtained from patients with sickle cell disease and from blood donors of African descent. DNA extractions and analyses were performed by standard methods. In the United States, none of 70 patient samples had the RHCE*818 nucleotide change. Two of 220 donors (frequency of 0.009) were heterozygous for RHCE*818C/T (RHCE*ceBI). One of these samples had RHD/RHD*DOL and the other had RHD/RHD*DOL-2. In these 290 samples, no other RHD*DOL alleles were found. In Brazil, 1 of 244 patients with sickle cell disease (frequency of 0.004) and 1 of 171 donors (frequency of 0.006) were heterozygous for RHCE*818C/T (RHCE*ceBI). Testing of more than 500 additional samples from people of African descent, selected because they had a diverse range of common and variant RHCE alleles, did not reveal a sample with RHD*DOL or RHD/RHD*DOL-2 in the absence of RHCE*ce(818T). Although the numbers are small, our study shows that in the United States, the frequency of RHCE*818T is 0.007 (2 in 290 samples) and in Brazil it is 0.004 (2 in 515 samples). The four RHCE*818T alleles were RHCE*ceBI.
Collapse
Affiliation(s)
- C Halter Hipsky
- Laboratory of Immunochemistry, New York Blood Center, New York, NY 10065, USA
| | | | | | | | | | | |
Collapse
|
30
|
Gutarrra M, Godoy M, Silva M, Silva J, Castilho L, Freire D. Development and operation of a multi-proposal solid-state fermentation bioreactor for lipase production using an agro-industrial residue as culture medium. N Biotechnol 2009. [DOI: 10.1016/j.nbt.2009.06.223] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
|
31
|
Baglioni P, Neto W, Kato L, Castilho L. Abstract: P942 REGULAR AEROBIC MODERATE EXERCISE IN YOUNG MALES LEADS TO A DECREASE IN CETP ACTIVITY AND PROMOTES VLDL AND LDL FAVORABLE COMPOSITION CHANGES. ATHEROSCLEROSIS SUPP 2009. [DOI: 10.1016/s1567-5688(09)71063-3] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
32
|
Santiago F, Nakamura R, Castilho L, de Faria E. Abstract: 547 HYPERALPHALIPOPROTEINEMIC INDIVIDUALS HAVE PROTECTIVE MODULATION OF CAROTID INTIMA-MEDIA THICKNESS. ATHEROSCLEROSIS SUPP 2009. [DOI: 10.1016/s1567-5688(09)70284-3] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
|
33
|
Ribeiro KR, Guarnieri MH, da Costa DC, Costa FF, Pellegrino J, Castilho L. DNA array analysis for red blood cell antigens facilitates the transfusion support with antigen-matched blood in patients with sickle cell disease. Vox Sang 2009; 97:147-52. [PMID: 19392786 DOI: 10.1111/j.1423-0410.2009.01185.x] [Citation(s) in RCA: 66] [Impact Index Per Article: 4.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/30/2023]
Abstract
BACKGROUND Blood samples from patients with sickle cell disease (SCD) present to transfusion service with numerous antibodies, making the searching for compatible red blood cells (RBC) a challenge. To overcome this problem we developed an effective strategy to meet needs of supplying RBC-compatible units to SCD patients using DNA arrays. METHODS We selected DNA samples from 144 SCD patients with multiple (receiving > 5 units) transfusions previously phenotyped for ABO, Rh(D, C, c, E, e), K1, Fy(a) and Jk(a). We also selected DNA samples from 948 Brazilian blood donors whose ABO/RhD phenotype matched that of the patients. All samples were analysed by DNA array analysis (HEA Beadchip(TM), Bioarray Solutions) to determine polymorphisms associated with antigen expression for 11 blood group systems (Rh, Kell, Kidd, Duffy, MNS, Dombrock, Lutheran, Landsteiner-Wiener, Diego, Colton, Scianna); and one mutation associated with haemoglobinopathies. RESULTS Based on genotype results we were able to predict phenotype-compatible donors needed in order to provide compatible units to this group of patients. Based on their ABO/Rh phenotype we were able to find in this pool of donors compatible units for 134 SCD patients. CONCLUSION Blood group genotyping by DNA array contributes to the management of transfusions in SCD patients by facilitating the transfusion support with antigen-matched blood. It has the potential to improve the life of thousands of SCD-transfused patients by reducing mortality due to transfusion reactions and immunization.
Collapse
Affiliation(s)
- K R Ribeiro
- Hemocentro Unicamp, Rua Carlos Chagas 480, Campinas, São Paulo, Brazil
| | | | | | | | | | | |
Collapse
|
34
|
Abstract
BACKGROUND JAL (RH48) is a low-prevalence antigen in the Rh blood group system and anti-JAL has caused hemolytic disease of the newborn. JAL is associated with either a haplotype carrying depressed C and e antigens or one carrying depressed c and e antigens. Blood samples from JAL+ people were tested, published serologic findings were confirmed, serologic studies were extended to include expression of other Rh antigens, and the antibody specificities produced by three sensitized JAL+ probands are reported. STUDY DESIGN AND METHODS Red blood cell (RBC) samples from 17 (12 probands) JAL+ persons were tested by hemagglutination using standard methods. RESULTS RBCs from both the Caucasian JAL+ probands had the (C)(e) haplotype and weakened C, e, hr(B), and hr(S) antigens. JAL+ samples from black persons had the (c)(e) haplotype and expressed weakened c, e, f, V, VS, hr(B), and hr(S) antigens. Plasma from three sensitized c+e+ JAL+ probands contained alloanti-c, alloanti-e, or alloantibody of apparent anti-Rh17 specificity. This study shows that this alloanti-Rh17-like antibody recognizes the high-prevalence antigen antithetical to JAL that has been named CEST. CONCLUSIONS The presence of the JAL antigen has a quantitative (weakening) effect on the expression of C, e, hr(B), and hr(S) antigens in Caucasian persons and of c, e, f, V, VS, hr(B), and hr(S) antigens in people of black African ancestry. A qualitative effect also was demonstrated by the presence of alloanti-c or alloanti-e in the plasma of two transfused c+e+ patients and by an antibody (anti-CEST) that recognizes the high-prevalence antigen antithetical to JAL.
Collapse
Affiliation(s)
- Christine Lomas-Francis
- Laboratory of Immunohematology, New York Blood Center, 310 East 67th Street, New York, NY 10065, USA
| | | | | | | | | | | | | |
Collapse
|
35
|
Daniels G, Castilho L, Flegel WA, Fletcher A, Garratty G, Levene C, Lomas-Francis C, Moulds JM, Moulds JJ, Olsson ML, Overbeeke M, Poole J, Reid ME, Rouger P, van der Schoot E, Scott M, Sistonen P, Smart E, Storry JR, Tani Y, Yu LC, Wendel S, Westhoff C, Yahalom V, Zelinski T. International Society of Blood Transfusion Committee on terminology for red blood cell surface antigens: Macao report. Vox Sang 2009; 96:153-6. [PMID: 19152607 DOI: 10.1111/j.1423-0410.2008.01133.x] [Citation(s) in RCA: 59] [Impact Index Per Article: 3.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
Affiliation(s)
- G Daniels
- Bristol Institute for Transfusion Sciences and The International Blood Group Reference Laboratory, NHS Blood and Transplant, Filton, Bristol, UK.
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
36
|
van der Schoot CE, de Haas M, Engelfriet CP, Reesink HW, Panzer S, Jungbauer C, Schwartz DMW, Mayr WR, Castilho L, St-Louis M, Long A, Denomme G, Semple E, Fernandes B, Flegel WA, Wagner F, Doescher A, Poli F, Villa MA, Paccapelo C, Karpasitou K, Veldhuisen B, Nogués N, Muñiz-Diaz E, Daniels G, Martin P, Finning K, Reid ME. Genotyping for red blood cell polymorphisms. Vox Sang 2009; 96:167-79. [DOI: 10.1111/j.1423-0410.2008.01131.x] [Citation(s) in RCA: 21] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
37
|
Denomme GA, Westhoff CM, Castilho L, Reid ME. Consortium for Blood Group Genes (CBGG): 2008 report. Immunohematology 2009; 25:75-80. [PMID: 19927624] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 05/28/2023]
Abstract
The Consortium for Blood Group Genes is a worldwide organization whose goal is to have a vehicle to interact, establish guidelines, operate a proficiency program, and provide education for laboratories involved in DNA and RNA testing for the prediction of blood group, platelet, and neutrophil antigens.
Collapse
Affiliation(s)
- G A Denomme
- Immunohematology Reference Laboratory, Blood Center of Wisconsin, Milwaukee, WI 53201-72178, USA
| | | | | | | |
Collapse
|
38
|
Omoto R, Reid ME, Castilho L. Molecular analyses of GYPB in African Brazilians. Immunohematology 2008; 24:148-153. [PMID: 19856717] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 05/28/2023]
Abstract
The molecular background of variant forms of GYPB is not well studied in Brazilians of African descent. The present study was carried out to determine the molecular bases of the S-s- phenotype and the frequency of GYPB*S silent gene for the S-s+ phenotype in a blood donor population of African Brazilians. In this study, 165 blood samples from African Brazilians (Northeastern Brazil) who phenotyped as S-s- (n = 17) and S-s+ (n = 148) by hemagglutination were selected. Allele-specific (AS)-PCR and PCR-restriction fragment length polymorphism (RFLP) were used to identify the variant forms of GYPB. In 13 of 17 S-s- samples (76.5%), both GYPB were deleted. In 137 of the 148 S-s+ samples (92.6%), the AS-PCR was consistent with the S-s+ phenotype. In 4 of the S-s- samples (23.5%) and 11 of the S-s+ samples (7.4%), the AS-PCR showed the presence of a GYPB*S allele associated with silencing of S. In the 4 donors with the S-s- phenotype, there was homozygosity (or hemizygosity) for the GYP(P2) allele (n = 2), homozygosity (or hemizygosity) for the GYP(NY) allele (n = 1), and heterozygosity for the GYP(P2) and GYP(NY) alleles (n = 1). In the 11 donors with the S-s+ phenotype, there was heterozygosity for GYP(P2) allele (n = 8) and heterozygosity for GYP(NY) allele (n = 3). This study reports for the first time the molecular mechanisms responsible for the S-s- phenotype in a population of African Brazilians and provides new information about the frequency and molecular bases of the GYPB*S silent gene (7.4%) in this population.
Collapse
Affiliation(s)
- R Omoto
- Hospital São Rafael, Salvador, BA, Brazil
| | | | | |
Collapse
|
39
|
Castilho L, Baleotti W, Tossas E, Hue-Roye K, Ribeiro KR, Lomas-Francis C, Charles-Pierre D, Reid ME. Molecular studies of DO alleles reveal that JO is more prevalent than HY in Brazil, whereas HY is more prevalent in New York. Immunohematology 2008; 24:135-137. [PMID: 19856715] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 05/28/2023]
Abstract
Because of the scarcity of anti-Hy and anti-Jo(a), hemagglutination typing for the Dombrock blood group system antigens, Hy and Jo(a), is not feasible. The molecular bases associated with these antigens have been determined, making it possible to distinguish HY and JO from wild-type DO. This provides a tool to predict the probable phenotype of patients and to screen for antigen-negative donors. PCR-RFLP assays and a microchip assay were used to determine the frequency of HY and JO alleles in donors from Brazil and New York. DNA from random Brazilian donors, 288 by PCR-RFLP and 599 by the bead array method (BeadChip, BioArray Solutions, Warren, NJ), was tested to determine 323G/T (HY+/HY-) and 350C>T (JO+/JO-) single-nucleotide polymorphisms. In New York, 27,226 donors who self-identified as being African American were tested by hemagglutination with anti-Gy(a). Nonreactive and weakly reactive samples were tested by PCR-RFLP for the same alleles as listed above. In Brazil, 30 (3.4%) of the samples were JO/DO and 13 (1.4%) were HY/DO. In New York, of the samples that had HY or JO alleles, 14 were homozygous HY/HY 132 were heterozygous HY/DO, 13 were heterozygous HY/JO, 14 were heterozygous JO/DO, and 3 were homozygous JO/JO. These results show that in donors from Brazil, JO (30 alleles) is more than twice as prevalent as HY (13 alleles), whereas in donors from New York, HY (173 alleles) was more than five times more common than JO (33 alleles).
Collapse
Affiliation(s)
- L Castilho
- Hemocentro, Universidade de Campinas, Campinas, São Paulo, Brazil
| | | | | | | | | | | | | | | |
Collapse
|
40
|
Reid ME, Westhoff CM, Denomme G, Castilho L. Consortium for Blood Group Genes (CBGG): Miami 2006 report. Immunohematology 2007; 23:81-84. [PMID: 18004939] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 05/25/2023]
Affiliation(s)
- M E Reid
- Laboratory of Immunochemistry and Laboratory of Immunohematology, New York Blood Center, 310 East 67th Street, New York, NY 10021, USA
| | | | | | | |
Collapse
|
41
|
Reid ME, Westhoff C, Denomme G, Castilho L. Consortium for Blood Group Genes (CBGG): 2007 report. Immunohematology 2007; 23:165-168. [PMID: 18284308] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 05/25/2023]
Abstract
The Consortium for Blood Group Genes is a worldwide organization whose goal is to have a vehicle to interact, establish guidelines, operate a proficiency program, and provide education for laboratories involved in DNA and RNA testing for the prediction of blood group, platelet, and neutrophil antigens.
Collapse
Affiliation(s)
- M E Reid
- Laboratory of Immunochemistry, New York Blood Center, 310 East 67th Street, New York, NY 10021, USA
| | | | | | | |
Collapse
|
42
|
Santos A, D’Ippolito G, Castilho L, Amilcar M, Srougi M. MP-20.04. Urology 2006. [DOI: 10.1016/j.urology.2006.08.585] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
43
|
Santos A, D’Ippolito G, Castilho L, Amilcar M, Srougi M, Valim A. V-03.06. Urology 2006. [DOI: 10.1016/j.urology.2006.08.1001] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]
|
44
|
Abstract
BACKGROUND AND OBJECTIVES The Doa and Dob polymorphisms are associated with three single nucleotide polymorphisms (SNPs) in exon 2 of the DO gene: 378C/T, 624T/C and 793A/G for the DOA and DOB alleles, respectively. The SNPs 350C/T (JO allele) and 323G/T (HY allele) are associated with the Jo(a-) and Hy-negative phenotypes. Recently, two new DO alleles [DOB-SH (378C, 624C, 793G) and DOA-HA (378T, 624T, 793A)] were identified using microarray technology. Although the molecular background of Dombrock alleles is well defined, no studies have been conducted in the Brazilian population. MATERIALS AND METHODS We employed polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP)-based assays and a microarray assay to determine the frequency of the DO alleles (DOA, DOB, HY1, HY2 and JO) in Brazilians. We tested DNA of 288 Brazilians from three different ethnic groups by PCR-RFLP to determine the 793A/G (DOA/DOB), 323G/T (HY), 350C/T (JO) and 898C/G (HY1/HY2) SNPs. We also tested DNA from 162 blood donors by using the HEA Beadchip assay to determine the 378C/T, 624T/C, 793A/G (DOA/DOB), 350C/T (JO allele) and 323G/T (HY) SNPs. RESULTS Two novel allele combinations were found in our samples: the DOB allele (793G and 323G) associated with 898G (DOB-WL); and an allele carrying the nucleotides 378C, 624C, 793A and 323G (DOA-SH). We also found the DOB-SH and DOA-HA.alleles recently reported. CONCLUSIONS Our data demonstrate high heterogeneity of DO alleles in the Brazilian population. Our study also highlights the importance of testing a cohort of different populations to determine DO haplotypes and of establishing reliable genotyping tests for predicting Doa/Dob status.
Collapse
Affiliation(s)
- W Baleotti
- Hemocentro, Faculdade de Medicina, Marília, SP, Brazil
| | | | | | | | | | | | | |
Collapse
|
45
|
Mota M, Rodrigues A, Fonseca NL, Kutner JM, Castilho L. The above letter was sent to Dr Mota et al.: Dr Mota and colleagues offered the following reply. Transfusion 2006; 46:1062-3. [PMID: 16734830 DOI: 10.1111/j.1537-2995.2006.00848.x] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
|
46
|
Rosa KA, Reid ME, Lomas-Francis C, Powell VI, Costa FF, Stinghen ST, Watanabe AM, Carboni EK, Baldon JP, Jucksch MMF, Castilho L. Rhnull syndrome: identification of a novel mutation in RHce. Transfusion 2005; 45:1796-8. [PMID: 16271106 DOI: 10.1111/j.1537-2995.2005.00605.x] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
Abstract
BACKGROUND The deficiency of Rh proteins on red blood cells (RBCs) from individuals of the Rh(null) amorph type are the result of homozygosity for a silent RHCE in cis with a deleted RHD. A novel mutation in RHce was identified in two Caucasian Brazilian girls with the amorph type of Rh(null) who were born to parents who were first cousins. STUDY DESIGN AND METHODS RBCs from the Rh(null) sisters and from family members were analyzed by serology and flow cytometry with specific antibodies. Genomic DNA and transcripts were tested by polymerase chain reaction and sequence analysis. RESULTS Rh(null) RBCs were nonreactive with anti-Rh and anti-LW. Molecular analyses showed a deletion of RHD and of one nucleotide (960/963; GGGG-->GGG) in exon 7 of the RHce. This deletion introduced a frameshift after Gly321, a new C-terminal sequence, and a premature stop codon, resulting in a shorter predicted protein with 357 amino acids. CONCLUSION The detection of a unique RHce transcript indicated that the two sisters were homozygous, whereas the other family members were heterozygous for the mutation. A novel mutation resulting in the amorph Rh(null) with loss of Rh antigen expression is described.
Collapse
Affiliation(s)
- K A Rosa
- Hemocentro Unicamp, Campinas, SP, Brazil
| | | | | | | | | | | | | | | | | | | | | |
Collapse
|
47
|
Affiliation(s)
- M Mota
- Departamento de Hemoterapia, Hospital Israelita Albert Einstein, SP, Brazil.
| | | | | | | | | |
Collapse
|
48
|
Abstract
The GATA box single nucleotide polymorphism (SNP) at position -33 (T>C) in Blacks silences the expression of FY*B in erythrocytes, and the substitution 265 C>T, together with 298 G>A, weakens the Fy(b) antigen (Fy(x)). Individuals with these phenotypes/genotypes who receive Fy(b+) blood are unlikely to be alloimmunized to Fy(b) because, in the presence of 265 T, the Fy(b) antigen is expressed, and in the case of -33 C, other tissues express Duffy protein and probably the Fy(b) antigen. We studied samples from 361 blood donors (182 of African ancestry and 179 of Caucasian ancestry) by haemagglutination and polymerase chain reaction (PCR) restriction fragment length polymorphism (RFLP). Forty Caucasian and 130 donors of African ancestry were serologically Fy(b-); among these, the majority of the donors of African ancestry had FY*B with the GATA SNP, while the majority of Caucasians typing Fy(b-) had FY*B with 265 T/298 A SNPs. Six of the Fy(b-) donors (three Africans and three Caucasians) had both GATA and 265/298 SNPs, and six donors of Caucasian ancestry apparently had a GATA SNP. Samples from two donors - one African and one Caucasian with an unusual MspA1I-RFLP pattern - were sequenced and found to have a novel SNP (145 G>T) co-existent with 265 C>T and 298 G>A SNPs. These findings highlight the importance of establishing the incidence and nature of molecular events that impact on Duffy expression in different populations.
Collapse
Affiliation(s)
- L Castilho
- Hemocentro, Unicamp, Campinas, São Paulo, Brazil.
| | | | | | | | | | | |
Collapse
|
49
|
Castilho L, Rios M, Rodrigues A, Pellegrino J, Saad STO, Costa FF. High frequency of partial DIIIa and DAR alleles found in sickle cell disease patients suggests increased risk of alloimmunization to RhD. Transfus Med 2005; 15:49-55. [PMID: 15713129 DOI: 10.1111/j.1365-3148.2005.00548.x] [Citation(s) in RCA: 22] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
Abstract
We have set out to determine the frequency of DIIIa and DAR alleles among sickle cell disease (SCD) patients. These D variants permit the unexpected development of antibodies to RhD among individuals who are otherwise classified as RhD+. DNA samples from 130 SCD patients were tested for 455A>C (specific for DIIIa), 602C>G, 667T>G (common for both DIIIa and DAR) and 1025T>C (specific for DAR) by polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) and sequence analysis. The PCR-RFLP showed that 12 (9.2%) of the SCD patients were carrying DIIIa and DAR alleles. Genomic DNA analysis performed by sequence showed that three samples were heterozygous DIIIa (2.3%), seven heterozygous DAR (4.6%) and two (1.5%) samples carried a partial D with four mutations: 455A>C (heterozygous), 602C>G and 667T>G (homozygous) and 1025T>C (heterozygous), indicating compound heterozygosity for one DIIIa allele and one DAR allele. The predicted phenotypes of eight (6.2%) SCD patients were DIIIa, DAR and DIIIa/DAR. Three patients were anti-D immunized (DAR, n = 1; DIIIa/DAR, n = 2). These findings suggest that SCD patients who are candidates for chronic transfusion may benefit from genotyping for DIIIa and DAR to prevent alloimmunization.
Collapse
Affiliation(s)
- L Castilho
- Hemocentro Unicamp, Campinas, SP, Brazil.
| | | | | | | | | | | |
Collapse
|
50
|
Kaplan D, Schreiber R, Oliveira H, Cruz M, Tentor J, Harada L, Castilho L, Nakamura R, de Faria E. W14.366 Genetics of cholesteryl ester transfer protein in a Brazilian population. ATHEROSCLEROSIS SUPP 2004. [DOI: 10.1016/s1567-5688(04)90365-6] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/26/2022]
|